enVVeno Medical
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -124 | -117 | -120 | |
EBITDA | -3,767 | -3,938 | -3,619 | -4,419 |
EBIT | -3,796 | -4,062 | -3,736 | -4,539 |
Net Income | -3,600 | -3,849 | -3,736 | -4,539 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,549 | -3,238 | -3,443 | -4,392 |
Cash | 2,841 | 2,597 | 3,065 | 1,544 |
Basic Shares | 671 | 654 | 16 | 16 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -489 | -528 | -546 | -525 |
EBITDA | -18,983 | -21,291 | -22,970 | -24,144 |
EBIT | -19,472 | -21,819 | -23,516 | -24,669 |
Net Income | -19,472 | -21,819 | -23,516 | -24,669 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -50,173 | |||
Free Cash Flow | -15,573 | -16,875 | -18,891 | -15,734 |
Cash | 3,065 | 1,754 | 3,620 | 4,555 |
Basic Shares | 589 | 13 | 10 | 9 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$5.37 |
2026-03-31 | -$5.89 |
2025-12-31 | -$5.90 |
2025-09-30 | -$0.23 |